First Board Meeting of 2026

The Board met in Berlin in March for a two-day session. In addition to reports on, among other things, the Federal Government’s Pharmaceutical Dialogue, the High-Tech Agenda, and the EU Biotech Act, the operational strategy of the secretariat and the association was a central topic of the meeting. Another topic was cooperation with other associations. On the morning of the second day of the Executive Board meeting, the Executive Board members met with members of the “Life Science Research” department of the “Association of the Diagnostics Industry” (VDGH).